Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
United States Naval Medical Center, San Diego
This is a randomized single-blind pilot study investigating the efficacy of high-frequency repetitive transcranial magnetic stimulation (rTMS) applied to the right dorsolateral prefrontal cortex at either 10 Hz or 20 Hz as compared to a treatment as usual group for the treatment of Post Traumatic Stress Disorder (PTSD) symptoms.
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Willing and able to give informed consent
Diagnosis of Post-Traumatic Stress Disorder as determined by the SCID
CAPS score of at least 40
Males or females between 18-65 years of age
Willing to give up new psychotherapy or changes in psychiatric medications during the course of the TMS treatment.
You may not be if
Current primary Axis I disorder including Schizophrenia, Bipolar Disorder type I, Major Depressive Disorder
Patients with HDRS score ≥ 18
A metallic implant in cranium (except the mouth)
Patients with severe or unstable medical conditions, which in the opinion of the investigator would interfere with their progress or safety
ECT treatment within the last three months
Patients with a history of epilepsy
Patients with neurological disorder leading to increased intracranial pressure
Participation in a new course of psychotherapy during the 24 days of the study
A new psychiatric medication within 6 weeks of enrolling in the study
Changes in psychiatric medication within 2 weeks of starting the study
Clareo Health | High-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in PTSD
